Trial Profile
Clinical Trials Insight: 700060719
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Oct 2010
Price :
$35
*
At a glance
- Drugs Quercetin (Primary)
- Indications Respiratory tract infections
- Focus Therapeutic Use